Brief: Marker Therapeutics Announces Comprehensive Non-Dilutive Agreement With Cellready

Marker Therapeutics

01/05/2023 12:34

May 1 (Reuters) - Marker Therapeutics Inc  MRKR.O :
    * MARKER THERAPEUTICS ANNOUNCES COMPREHENSIVE NON-DILUTIVE
AGREEMENT WITH CELLREADY™
    * MARKER THERAPEUTICS INC: CELLREADY WILL PURCHASE CERTAIN
CELL
MANUFACTURING ASSETS FROM MARKER FOR APPROXIMATELY $19 MILLION
IN CASH
    * MARKER THERAPEUTICS INC: DEAL WILL REDUCE MARKER'S
OVERHEAD BY
ABOUT $11 MILLION ANNUALLY
    * MARKER THERAPEUTICS INC: AGREEMENT ALLOWS MARKER TO
CONCENTRATE
SOLELY ON CLINICAL ADVANCEMENT OF ITS UNIQUE FORM OF T CELL
THERAPY

Source text for Eikon:  ID:nGNX1LQ1F3 
Further company coverage:  MRKR.O 

 ((Reuters.Briefs@thomsonreuters.com;))